Unveiling the benefts of Vitamin D3 with SGLT-2 inhibitors for hypertensive obese obstructive sleep apnea patients

Background Obstructive sleep apnea (OSA) is associated with poorer quality of life (QoL) and increased cardiovascular risks, which may be exacerbated by hypovitaminosis D. Sodium glucose transporter-2 inhibitor (SGLT2i) provides cardiovascular benefts beyond glycemic control. As vitamin D3 and SGLT...

Full description

Saved in:
Bibliographic Details
Main Authors: Loh, Huai Heng, Tay, Siow Phing, Koa, Ai Jiun, Yong, Mei Ching, Asri, Said, Chai, Chee Shee, Natasya Marliana, Abdul Malik, Anselm Su, Ting, Bonnie Tang, Bao Chee, Florence Tan, Hui Sieng, Norlela, Sukor
Format: Article
Language:en
Published: BioMed Central Ltd. 2025
Subjects:
Online Access:http://ir.unimas.my/id/eprint/47737/1/Unveiling%20the%20benefits.pdf
http://ir.unimas.my/id/eprint/47737/
https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-025-06312-w#:~:text=This%20is%20the%20first%20study,QoL%20in%20this%20patient%20population.
https://doi.org/10.1186/s12967-025-06312-w
Tags: Add Tag
No Tags, Be the first to tag this record!